We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 747 results
  1. Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma

    Background

    Ferroptosis, iron-dependent cell death, is an established mechanism for cancer suppression, particularly in hepatocellular carcinoma (HCC)....

    Youmei **ao, Zhanxue Xu, ... Hongbo Chen in Biomaterials Research
    Article Open access 01 July 2023
  2. Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases

    Background

    Brain-derived exosomes released into the blood are considered a liquid biopsy to investigate the pathophysiological state, reflecting the...

    Yoon Ok Jang, Hee-Sung Ahn, ... Yong Shin in Biomaterials Research
    Article Open access 16 February 2023
  3. Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy

    Doxorubicin (DOX) is an efficient chemotherapeutic agent widely used to treat different types of cancer; however, there is an inherent risk of...

    Laís E. Scheeren, Daniele R. Nogueira-Librelotto, ... Clarice M. B. Rolim in Journal of Nanoparticle Research
    Article 14 March 2020
  4. Dual-ratiometric magnetic resonance tunable nanoprobe with acidic-microenvironment-responsive property to enhance the visualization of early tumor pathological changes

    The development of microenvironment-responsive nanoprobes has shown great promise for use in magnetic resonance imaging (MRI), with the advantage of...

    Rong Cao, Ning Tang, ... Zhongling Wang in Nano Research
    Article 15 April 2023
  5. Preparation of transferrin-conjugated poly-ε-caprolactone nanoparticles and delivery of paclitaxel to treat glioblastoma across blood–brain barrier

    The delivery of anticancer drug to the brain remains a major challenge due to the existence of blood–brain barrier (BBB). Receptor-mediated...

    Geetha B. Heggannavar, Shaluah Vijeth, Mahadevappa Y. Kariduraganavar in Emergent Materials
    Article 18 July 2019
  6. A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer

    Background

    Theranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic...

    Madeeha Shahzad Lodhi, Muhammad Tahir Khan, ... Dong Qing Wei in Cancer Nanotechnology
    Article Open access 09 October 2021
  7. Recent Developments in Quantum Dots Technologies as Effective Theranostic Tools Against Cancer

    Cancer, being a condition of unhindered cell growth ultimately leading to the death of the patient, is very prominent in modern society. Despite all...
    Aniket Mukherjee, Nandini Sarkar in Application of Quantum Dots in Biology and Medicine
    Chapter 2022
  8. Liposomal Delivery System

    Liposomes are biodegradable and biocompatible lipid bilayer vesicles that are employed as potential carriers for the delivery of drugs to the desired...
    Sarjana Raikwar, Pritish Kumar Panda, ... Sanjay K. Jain in Nanotechnology for Biomedical Applications
    Chapter 2022
  9. Selective cytotoxic effects of nitrogen-doped graphene coated mixed iron oxide nanoparticles on HepG2 as a new potential therapeutic approach

    New selective therapeutics are needed for the treatment of hepatocellular carcinoma (HCC), the 7th most common cancer. In this study, we compared the...

    Zeynep Demir, Berkay Sungur, ... Aysun Özkan in Discover Nano
    Article Open access 22 February 2024
  10. Carrier-free programmed spherical nucleic acid for effective ischemic stroke therapy via self-delivery antisense oligonucleotide

    Antisense oligonucleotide (ASO) for anti-apoptosis is emerging as a highly promising therapeutic agents for ischemic stroke with complex pathological...

    Wenyan Yu, Cui** Xuan, ... **** Shi in Nano Research
    Article 24 May 2022
  11. Effect of acid-alkali treatment on serum protein adsorption and bacterial adhesion to porous titanium

    Modification of the titanium (Ti) surface is widely known to influence biological reactions such as protein adsorption and bacterial adhesion in...

    Juan Zhong, Xuelian Li, ... Ke Zhao in Journal of Materials Science: Materials in Medicine
    Article Open access 02 February 2022
  12. Targeting of Drug Nanocarriers

    Nanostructured drug delivery systems can be functionalized, through non-covalent interaction or mainly by covalent bonding, with ligands for...
    Josimar O. Eloy, Raquel Petrilli, Robert J. Lee in Nanocarriers for Drug Delivery
    Chapter 2021
  13. Nanoparticles for Brain Tumor Imaging and Therapy

    Nanoparticles have emerged as promising tools in the field of brain tumor imaging and therapy, offering unprecedented opportunities for precise...
    Cleona Elizabeth Mary DCruz, Rupesh Kalidas Shirodkar, ... Lalit Kumar in Nanomaterials for Drug Delivery and Neurological Diseases Management
    Chapter 2024
  14. Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leukemia Cells

    Leukemia is a typical blood cancer that is characterized by the numerous duplication and proliferation of white blood cells. The main aim of this...

    Yang Dai, **gcao Huang, ... Chuan He in Nanoscale Research Letters
    Article Open access 06 September 2018
  15. Engineering nanomaterials for glioblastoma nanovaccination

    Glioblastoma is a lethal brain cancer with treatment resistance stemming from its interactions with the surrounding microenvironment and obstacles...

    Fatima Hameedat, Bárbara B. Mendes, ... Flávia Sousa in Nature Reviews Materials
    Article 23 May 2024
  16. Gold nanoparticle-based drug nanocarriers as a targeted drug delivery system platform for cancer therapeutics: a systematic review

    Cancer was the world’s second major cause of death. Several treatments were available, including chemotherapy, radiotherapy, immunotherapy, and...

    A’liyatur Rosyidah, Supavadee Kerdtoob, ... Asef Wildan Munfadlila in Gold Bulletin
    Article 03 August 2023
  17. Targeted drug delivery in cancer using nanomaterials: advances and challenges

    Cancer is considered the world’s deadliest disease, and its underlying pathology is intricate. Though cancer patients have had access to...

    Teenu Sharma, Sakshi Gorivale, Priyanka Bhandari in Journal of Nanoparticle Research
    Article 11 June 2024
  18. Nanocarriers for Drug Delivery: General Characteristics

    The escalating pace of disease transmission has prompted scientists to embark on innovative approaches to enhance the therapeutic efficacy of modern...
    Devendra Sillu, M. Sudhakara Reddy, Shekhar Agnihotri in Nanomaterials for Drug Delivery and Neurological Diseases Management
    Chapter 2024
  19. Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting

    Overcoming the blood–brain barrier (BBB) remains a substantial challenge in CNS drug delivery. This review explores the potential of lipid-based...

    Alaa Alqudah, Alaa A. Aljabali, ... Murtaza M. Tambuwala in Journal of Nanoparticle Research
    Article 03 June 2024
  20. Targeted Nano-based Drug Delivery in Alzheimer's Disease and Dementia

    Alzheimer's disease (AD), the utmost widespread neurodegenerative illness, contributes to an enormous and expanding healthcare burden and impairs...
    Payel Mal, Santosh Kumar Rath, Tripti Halder in Nanomaterials for Drug Delivery and Neurological Diseases Management
    Chapter 2024
Did you find what you were looking for? Share feedback.